What question did this study set out to answer?

To analyze the rates and economic implications of catheter-related bloodstream infections in hemodialysis patients.

March 28, 2026Kidney International Reports0 citationsOpen Access

Wcn26-2336 Citrate Accumulation in Patients Using Regional Isotonic Citrate Anticoagulation During Continuous Kidney Replacement Therapy

PIPamela Marie ImperialNational Kidney and Transplant Institute CTChristopher K. J. TeowTan Tock Seng Hospital BKBenjamin Zhi En KhooTan Tock Seng Hospital

Key Points

To analyze the rates and economic implications of catheter-related bloodstream infections in hemodialysis patients.
Retrospective chart review of outpatient hemodialysis patients
Review of clinical and demographic profiles from 2018 to 2023
Analysis of hospitalization costs and patient outcomes
Cumulative CRBSI rate was 0.9 per 1000 catheter days
Diabetes mellitus linked to worse outcomes, including longer hospital stays and higher mortality
Average hospitalization cost for CRBSI patients was PHP 338,069.70, with medications as the largest expense

Abstract

Methods: A retrospective design using a chart review of all outpatient hemodialysis patients with documented CRBSI from 2018 to 2023.Patient clinical and demographic profiles, outcomes, and total hospitalization costs were reviewed.Results: The overall cumulative CRBSI rate was 0.9 per 1000 catheter days.The presence of diabetes mellitus was associated with poorer outcomes, particularly prolonged hospital stay, increased CRBSI recurrence, and mortality rates.The average cost per hospitalization for CRBSI patients was PHP 338,069.70 ( 301,718.40),with medications accounting for the largest portion (PHP 54,825.85 58,589.45) of the total cost.Conclusion: This study found a low incidence rate of CRBSI, which falls within the target rate set by KDOQI.Despite its low incidence, CRBSI is associated with a significant economic burden, highlighting the importance of preventive measures to improve patient outcomes and reduce healthcare costs.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

AI से पूछें

Bookmark

View Full Paper